Compare ROIV & CAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ROIV | CAE |
|---|---|---|
| Founded | 2014 | 1947 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1B | 8.2B |
| IPO Year | 2021 | 2002 |
| Metric | ROIV | CAE |
|---|---|---|
| Price | $40.82 | $24.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $28.94 | ★ $33.33 |
| AVG Volume (30 Days) | ★ 7.9M | 723.2K |
| Earning Date | 05-28-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,260,000.00 | N/A |
| Revenue This Year | N/A | $4.97 |
| Revenue Next Year | $744.61 | N/A |
| P/E Ratio | ★ N/A | $35.13 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.83 | $22.76 |
| 52 Week High | $42.50 | $34.24 |
| Indicator | ROIV | CAE |
|---|---|---|
| Relative Strength Index (RSI) | 66.10 | 36.94 |
| Support Level | $33.15 | $23.01 |
| Resistance Level | N/A | $27.11 |
| Average True Range (ATR) | 1.37 | 0.56 |
| MACD | 0.53 | -0.10 |
| Stochastic Oscillator | 78.11 | 21.72 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: i) Civil Aviation: Provides comprehensive training solutions for flight, cabin, maintenance, ground personnel and air traffic controllers in commercial, business and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training and crew sourcing services, as well as airline operations digital solutions; and ii) Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.